Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Minor formatting/layout adjustments observed; no changes to core study data (title, conditions, interventions, eligibility criteria, or primary outcomes). To avoid being alert by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:29:08.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:52:11.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-29T03:11:24.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, indicating a minor core-content update; the 'Back to Top' link was removed as a small UI change.
    Difference
    0.1%
    Check dated 2025-09-14T19:55:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T16:53:42.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and location information, as well as additional publications related to acute myeloid leukemia and myelodysplastic syndromes. Notably, the revision number has changed to v3.0.0.
    Difference
    6%
    Check dated 2025-08-31T12:06:43.000Z thumbnail image

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.